GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $68,810,000 | +21954.5% | 1,580,742 | +21980.5% | 0.23% | +22600.0% |
| Q1 2022 | $312,000 | -99.6% | 7,159 | -99.6% | 0.00% | -99.4% |
| Q4 2021 | $84,790,000 | -35.8% | 1,922,670 | -44.4% | 0.18% | -38.6% |
| Q3 2021 | $132,102,000 | +4453.7% | 3,457,267 | +4645.1% | 0.30% | +4114.3% |
| Q2 2021 | $2,901,000 | -85.6% | 72,859 | -87.1% | 0.01% | -86.8% |
| Q1 2021 | $20,196,000 | +215.0% | 565,859 | +232.2% | 0.05% | +130.4% |
| Q3 2020 | $6,411,000 | -89.8% | 170,324 | -89.0% | 0.02% | -92.7% |
| Q2 2020 | $63,140,000 | +34.6% | 1,547,927 | +25.0% | 0.31% | -18.1% |
| Q1 2020 | $46,920,000 | +47.4% | 1,238,317 | +82.8% | 0.38% | +297.9% |
| Q4 2019 | $31,824,000 | -62.3% | 677,256 | -65.7% | 0.10% | -66.2% |
| Q3 2019 | $84,338,000 | +53.8% | 1,976,062 | +44.2% | 0.28% | +55.2% |
| Q2 2019 | $54,823,000 | -4.2% | 1,369,889 | +0.0% | 0.18% | -1.6% |
| Q1 2019 | $57,239,000 | +259.2% | 1,369,672 | +228.4% | 0.19% | +200.0% |
| Q4 2018 | $15,936,000 | +76.0% | 417,059 | +85.6% | 0.06% | +129.6% |
| Q2 2018 | $9,056,000 | -73.4% | 224,669 | -74.2% | 0.03% | -76.1% |
| Q1 2018 | $34,088,000 | -59.8% | 872,488 | -63.5% | 0.11% | -59.1% |
| Q4 2017 | $84,708,000 | +8.1% | 2,388,168 | +23.7% | 0.28% | -0.7% |
| Q3 2017 | $78,394,000 | -15.5% | 1,930,892 | -10.2% | 0.28% | -17.0% |
| Q2 2017 | $92,741,000 | +6.7% | 2,150,764 | +4.4% | 0.34% | +14.3% |
| Q1 2017 | $86,884,000 | -23.8% | 2,060,822 | -30.4% | 0.29% | -33.0% |
| Q4 2016 | $114,010,000 | +38.9% | 2,960,534 | +55.6% | 0.44% | +47.1% |
| Q3 2016 | $82,078,000 | -3.1% | 1,903,028 | -2.7% | 0.30% | -18.4% |
| Q2 2016 | $84,738,000 | +17.9% | 1,955,195 | +10.3% | 0.36% | +6.4% |
| Q1 2016 | $71,896,000 | +78.1% | 1,773,017 | +77.2% | 0.34% | +76.3% |
| Q4 2015 | $40,374,000 | -23.6% | 1,000,594 | -27.2% | 0.19% | -28.4% |
| Q3 2015 | $52,822,000 | -40.2% | 1,373,794 | -35.2% | 0.27% | -34.2% |
| Q2 2015 | $88,267,000 | -4.9% | 2,119,248 | +5.4% | 0.41% | -9.8% |
| Q1 2015 | $92,821,000 | +17.9% | 2,011,290 | +9.1% | 0.46% | +4.8% |
| Q4 2014 | $78,758,000 | -27.3% | 1,842,726 | -21.8% | 0.44% | -9.9% |
| Q3 2014 | $108,308,000 | +51.8% | 2,356,064 | +76.6% | 0.48% | +50.3% |
| Q2 2014 | $71,368,000 | +3.6% | 1,334,479 | +3.5% | 0.32% | -12.7% |
| Q1 2014 | $68,899,000 | +21.3% | 1,289,522 | +21.2% | 0.37% | +17.5% |
| Q4 2013 | $56,789,000 | +9.2% | 1,063,661 | +2.6% | 0.31% | -5.4% |
| Q3 2013 | $52,017,000 | -9.7% | 1,036,805 | -10.1% | 0.33% | -17.6% |
| Q2 2013 | $57,623,000 | – | 1,153,147 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |